tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Bio-Techne upgraded to Buy from Neutral at Citi
PremiumThe FlyBio-Techne upgraded to Buy from Neutral at Citi
2M ago
Strategic Divestiture and Focus on Core Strengths Justify Buy Rating for Bio-Techne
Premium
Ratings
Strategic Divestiture and Focus on Core Strengths Justify Buy Rating for Bio-Techne
3M ago
Bio-Techne’s Strong Q4 Performance and Strategic Moves Justify Buy Rating
Premium
Ratings
Bio-Techne’s Strong Q4 Performance and Strategic Moves Justify Buy Rating
3M ago
Bio-Techne to divest Exosome Diagnostics business to Mdxhealth
PremiumThe FlyBio-Techne to divest Exosome Diagnostics business to Mdxhealth
3M ago
Bio-Techne price target raised to $58 from $51 at Baird
Premium
The Fly
Bio-Techne price target raised to $58 from $51 at Baird
3M ago
Promising Long-Term Growth for Bio-Techne Amidst Current Challenges: A Buy Recommendation by Kyle Boucher
Premium
Ratings
Promising Long-Term Growth for Bio-Techne Amidst Current Challenges: A Buy Recommendation by Kyle Boucher
3M ago
Bio-Techne, USP collaborate to develop monoclonal antibody and gene therapy
PremiumThe FlyBio-Techne, USP collaborate to develop monoclonal antibody and gene therapy
4M ago
Airbnb, Zscaler downgraded: Wall Street’s top analyst calls
Premium
The Fly
Airbnb, Zscaler downgraded: Wall Street’s top analyst calls
5M ago
Bio-Techne price target lowered to $65 from $90 at Argus
Premium
The Fly
Bio-Techne price target lowered to $65 from $90 at Argus
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100